🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $HBH.DE and executed a BUY strategy, securing a +1.30% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ANAB

Anaptysbio Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP5.60%
MAX GAP RECORD18.60%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY7.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL